The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of frontline risk-adapted strategy on the overall survival (OS) of patients with newly diagnosed multiple myeloma (MM): A population study in Singapore (SG).
D. C. Tan
Honoraria - Janssen-Cilag (I)
Research Funding - Janssen-Cilag
K. H. Ong
No relevant relationships to disclose
L. P. Koh
No relevant relationships to disclose
S. S. Wong
No relevant relationships to disclose
M. T. Khin
No relevant relationships to disclose
L. H. Lee
No relevant relationships to disclose
Y. T. Goh
Honoraria - Janssen-Cilag
Research Funding - Janssen-Cilag
W. J. Chng
Honoraria - Janssen-Cilag